Market cap
₹641 Cr
Recently Viewed
Clear AllNSE: TAKE | BSE: 532890
₹43.56
₹-0.88
(-1.98%)
As on 29-Apr-2026IST
Market cap
₹641 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
398.5
P/B Ratio
23.8
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹2 Cr
ROE
12.7 %
ROCE
13.6 %
Industry P/E
406.57
EV/EBITDA
995.3
Debt to Equity
0
Book Value
₹1.8
EPS
₹-0
Face value
1
Shares outstanding
147,934,000
CFO
₹908.11 Cr
EBITDA
₹1,174.25 Cr
Net Profit
₹-49.45 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Take Solutions
| 9.1 | 12.1 | 13.3 | 420.4 | 40.4 | -2.3 | -10.5 |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Take Solutions
| 147.2 | -30.9 | -3.2 | -51.3 | -14.8 | -46.1 | -33.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Take Solutions
|
43.6 | 641.2 | 0.0 | 1.6 | -- | -0.5 | 398.5 | 23.8 |
| 181.3 | 2,842.5 | 2,796.8 | 118.8 | 8.1 | 2.3 | 23.9 | 0.4 | |
| 24.3 | 7.4 | 0.5 | 0.0 | 8.3 | -1.1 | -- | 1.9 | |
| 495.5 | 11,934.3 | 3,262.7 | 439.0 | 15.3 | 16 | 27.2 | 4.0 | |
| 60.4 | 219.1 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 2.2 | |
| 187.8 | 8,499.1 | 2,803.3 | 361.8 | 15.5 | 14 | 23.6 | 3.0 | |
| 1,055.1 | 22,371.7 | 2,169.9 | 332.9 | 20.9 | 15.4 | 67.2 | 9.4 | |
| 4,788.4 | 11,052.7 | 935.0 | 257.9 | 34.3 | 78.9 | 42.9 | 24.5 | |
| 27.8 | 61.8 | 51.4 | 4.5 | 22.0 | 5.2 | 13.7 | 0.6 |
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory... affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, DICOM devices, wearables, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is based in Chennai, India. Read more
Incorporated
2000
Chairman
--
Managing Director
--
Group
Take Solutions - MNC
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about Take Solutions Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Take Solutions Ltd is ₹43.56 (NSE) and ₹43.34 (BSE) as of 29-Apr-2026 IST. Take Solutions Ltd has given a return of 40.37% in the last 3 years.
The P/E ratio of Take Solutions Ltd is 398.47 times as on 29-Apr-2026, a 2 discount to its peers’ median range of 406.57 times.
The P/B ratio of Take Solutions Ltd is 23.83 times as on 29-Apr-2026, a 1168 premium to its peers’ median range of 1.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
2.63
|
4.81
|
|
2024
|
0.00
|
-34.11
|
|
2023
|
0.00
|
1.85
|
|
2022
|
0.00
|
2.48
|
|
2021
|
0.00
|
0.59
|
The 52-week high and low of Take Solutions Ltd are Rs 50.14 and Rs 7.30 as of 29-Apr-2026.
Take Solutions Ltd has a market capitalisation of ₹ 641 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Take Solutions Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.